Nesina and Pregnancy
Nesina (alogliptin) is generally considered safe to take during pregnancy. The FDA has classified the drug as a pregnancy Category B medication (it did not appear to cause harm to the fetus in animal studies). If you are pregnant or thinking of becoming pregnant, talk to your healthcare provider about whether this medication is right for you.
Nesina® (alogliptin) is a prescription medication used to improve blood glucose (blood sugar) control in people with type 2 diabetes. Nesina is generally considered safe for use in women who are expecting.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Nesina is classified as a pregnancy Category B medicine.
Pregnancy Category B is given to medicines that have not been adequately studied in pregnant women but did not appear to cause harm to the fetus in animal studies. Medications that have been shown to be safe for use in pregnancy in humans but have caused problems in laboratory animals are also given a Category B rating.
Nesina has not been studied in pregnant women. However, in animal studies, the drug did not cause birth defects or other problems when given to pregnant rats and rabbits, even at extremely high doses.
However, it is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if her healthcare provider believes that the benefits to the woman outweigh any possible risks to her unborn child.
If you have diabetes, it is important to work closely with your healthcare provider if you are pregnant or are thinking of becoming pregnant. Poor blood glucose control during pregnancy can be harmful to you and your baby. Therefore, you will need to discuss with your healthcare provider the best ways to monitor and control your blood glucose while you are pregnant.